, Tracking Stock Market Picks
Enter Symbol:
Tekmira Pharm Corp (TKMR) [hlAlert]

down 35.86 %

TEKMIRA PHARM CORP (TKMR) downgraded to Hold with price target $14 by Maxim Group

Posted on: Monday,  Jun 15, 2015  12:25 PM ET by Maxim Group

Maxim Group rated Hold Arbutus Biopharma Corporation (NASDAQ: ABUS) on 06/15/2015. Previously Maxim Group rated Buy Arbutus Biopharma Corporation (NASDAQ: ABUS) on
01/12/2015., when the stock price was $22.61. Since then, Arbutus Biopharma Corporation has lost 35.87% as of 06/15/2015's recent price of $14.50.
If you would have followed the previous Maxim Group's recommendation on ABUS, you would have lost 35.86% of your investment in 154 days.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy